Top501 BizWorld: Bristol-Myers, Lilly lead rebound in drug stocks

Posted in : articles.top501.nu    Tue, Oct 07 2008, 14:44

Top501 BizWorld: Bristol-Myers, Lilly lead rebound in drug stocks posted at Articles.Top501.nu. More or Videos The bid by Lilly, worth $70 a share, beat an offer of $62 a share from Bristol-Myers Squibb, which markets ImClones cancer drug Erbitux i... http://articles.top501.nu/2008/10/07/t...

[More related posts here] tags :  alimta ,   bizworld ,   blockbuster ,   bmy ,   bristol myers ,   Bristol-Myers ,   cancer drug ,   cancer patients ,   carl icahn ,   companies struggle

0 Comments Wow Hiss